Method Dependence of Interpretation of Immunoassay Results

References

• Yalow R S, Berson SA. Immunoassay of endogenous plasma insulin in man. J Clin Invest 1960; 39: 1157–75
   PubMed Web of Science ®Google Scholar
• Ekins RP. The estimation of thyroxine in human plasma by an electrophoretic technique. Clin Chim Acta 1960; 5: 453–9
   PubMed Web of Science ®Google Scholar
• Wide L, Bennich H, Johansson SG. Diagnosis of allergy by an in-vitro test for allergen antibodies. Lancet 1967; 25: 1105–7
   Google Scholar
• Miles L EM, Hales CN. Labelled antibodies and immunological assay systems. Nature 1968; 219: 186–9
   PubMed Web of Science ®Google Scholar
• Goslin JP. A decade of development in immunoassay methodology. Clin Chem 1990; 36: 1408–27
   PubMed Web of Science ®Google Scholar
• Jackson T M, Ekins RP. Theoretical limitations on immunoassay sensitivity. Current practice and potential advan Tages of fluorescent Eu * chelates as non-radiotopic tracers. J. Immunol. Meth. 1986; 87: 13–20
   PubMed Web of Science ®Google Scholar
• Stenman U-H, Tanner P, Ranta T, Schröder J M S. Monoclonal antibodies to chorionic gonadotropin. Use in a rapid radioimmunoassay for gynecologic emergencies. Obstet Gynecol 1982; 59: 375–7
   PubMed Web of Science ®Google Scholar
• Stenman U-H, Alfthan H, Myllynen L, Seppälä M. Ul-trarapid and highly sensitive lime-resolved fluoroim-munoassay for human chorionic gonadotropin. I-ancet 1983; ii: 647–9
   Google Scholar
• Stenman U-H, Alfthan H, Ranta T, Vartiainen E, Jalkanen J, Seppälä M. Serum levels of human chorionic gonadotropin in nonpregnant women and men are modulated by gonadotropin releasing hormone and sex steroids. J. Clin. Endocrinol. Metab. 1987; 64: 730–6
   PubMed Web of Science ®Google Scholar
• Lövgren T, Pettersson K. Time-resolved fluoroimmunoas-says, advan Tages and limitations. Luminescence Immunoassay and Molecular Applications, K van Dyke, R van Dyke. CRC Press, Inc., Boca Raton, Florida 1990; 233–53
   Google Scholar
• Soini E, Hemmila I. Fluoroimmunoassay: present status and key problem. Clin. Chem. 1979; 25: 353–361
   PubMed Web of Science ®Google Scholar
• Lövgren T, Hemmila I, Pettersson K, Eskola J, Benoft E. Determination of hormones by time-resolved fluoroimmunoassay. TalanU 1984; 31: 909–16
   PubMedGoogle Scholar
• Weeks I, Stuigess M, Siddle K, Jones M K, Woodhead JS. A high sensitivity immunochemiluminometric assay for human thyrotrophin. Clin Endocrinol 1984; 20: 489–95
   PubMed Web of Science ®Google Scholar
• Alfthan H. Comparison of immunoradiomelric and im-munofluorometric assays for serum hCG. J. Immunol. Meth. 1986; 88: 239–44
   PubMed Web of Science ®Google Scholar
• Stenman U-H, Alfthan H. Time-resolved fluoroimmunoas-says. Immunology, Biochemistry & Biotechnology. Recent Trends in Immuoassay Technology, in press
   Google Scholar
• Weber T H, Kapyaho K, Tanner P. Endogenous interference in immunoassays in clinical chemistry. A review. Scand J Clin Lab Invest 1990; 50: 77–82, Suppl 201
   PubMed Web of Science ®Google Scholar
• Turpeinen U, Lehtovirta P, Alfthan H, Stenman U-H. Interference by HAMA in CA 125 assay after immunoscintigra-phy: anti-idiotypic anditbodies not neutralized by mouse IgG but be removed by chromatography. Clin Chem 1990; 36: 1333–8
   PubMed Web of Science ®Google Scholar
• Dunn J F, Nisula B F, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981; 53: 58–68
   PubMed Web of Science ®Google Scholar
• Lobo R A, Granger L, Goebelsmann U, Mishel D. Elevations in unbound serum estradiol as a possible mechanisim for inappropriate gonadotropin secretion in women with PCO. J Clin Endocrinol Metab 1981; 52: 156–8
   PubMed Web of Science ®Google Scholar
• Vermeulen A. Testosterone and 5a-androstan-17B-ol-3-one (DHT) levels in man. Acta Endocrinol (Copenh) 1976; 83: 651–64
   PubMedGoogle Scholar
• Vermeulen A, Verdonck L, Van der Straten M, Orie M. Capacity of the testosterone binding globulin in human plasma and influence of specific binding of testosterone on its metabolic clearance rate. J Clin Endocrinol Metab 1969; 29: 1470
   Web of Science ®Google Scholar
• Hammond G L, Langley M S, Robinson P A, Nummi S A, Lund L. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or icvonorgestrel. Fertil Steril 1984; 42: 44–51
   PubMed Web of Science ®Google Scholar
• Ekins R P, Ellis SM. The radioimmunoassay of free thyroid hormones in serum. Thyroid research. Proceedings of the Seventh International Thyroid Conference, LE Braverman, J Robbins. ExcerpU Medica, Boston, Amsterdam 1976; 597–600
   Google Scholar
• Liewendahl K. Assessment of thyroid status by laboratory methods: developments and perspectives. Scand J Clin Lab Invest 1990; 50: 83–92, Suppl 201
   Web of Science ®Google Scholar
• Rajan M GR, Samuel AM. A two-step radioimmunoassay for free triiodothyronine in serum. Clin Chem 1987; 33: 372–6
   PubMed Web of Science ®Google Scholar
• Brien Human corticosteroid binding globulin. Clin Endocrinol 1981; 14: 193–212
   PubMed Web of Science ®Google Scholar
• Evans P J, Peters J R, Dyas J, Walker R F, Riad-Fahmy D, Hall R. Salivary Cortisol levels in true and apparent hyper-cortisolim. Clin Endocrinol 1984; 20: 709–15
   PubMed Web of Science ®Google Scholar
• Wide L, Gemzell CA. An immunological pregnancy test. Acta Endocrinol (Copenh) 1960; 35: 261–7
   PubMedGoogle Scholar
• Seppälä M, Tontti K, Ranta T, Stenman U-H, Chard T. Use of rapid hCG-bcla-subunit radioimmunoassay in acute gynaecological emergencies. Lancet 1980; 1: 165–6
   PubMed Web of Science ®Google Scholar
• Wilcox A J, Weinberg C R, O'Connor J F, et al. Incidence of early loss of pregnancy. N Engl J Med 1988; 319: 189–94
   PubMed Web of Science ®Google Scholar
• Ylöstalo P, Caccialore B, Koskimies A, et al. Conservative treatment of ectopic pregnancy. Ann NY Acad Sci, in press
   Google Scholar
• Schroeder H R, Halter CM. Specificity of human 6-chori-ogonadotropin assays for the hormone and for an im-munoreactive fragment present in the urine during normal pregnancy. Clin Chem 1983; 29: 667–71
   PubMed Web of Science ®Google Scholar
• Stenman U-H, Alfthan H, Koskimies A, Seppälä M, Pettersson K, Lövgren T. Monitoring the LH surge by ultrarapid and highly sensitive immunofluoromelric assay. Ann. NY. Acad. Sci. 1985; 442: 544–50
   PubMed Web of Science ®Google Scholar
• Khazaeli M B, Hedayat M M, Hatch K D, et al. Radioimmunoassay of free B-subunit of human chorionic gonadotropin as a prognostic test for persisitent trophoblastic disease in molar pregnancy. Am J Obstet Gynecol 1986; 155: 320–4
   PubMed Web of Science ®Google Scholar
• Alfthan H S, Schroder J., Fraser R., Koskimies A., Halila H, Stenman U.-H. Choriogonadotropin and its B subunit separated by hydrophobic interaction chromatography and and quantified in serum during pregnancy by time-resolved immunofluorometric assays. Clin. Chem. 1988; 9: 1758–62
   Google Scholar
• Sailer B, Clara R, Spoul G, Siddle K, Mann K. Testicular cancer secretes intact human gonadotropin (hCG) and its free β-subunit: evidence lhat hcg (+βhCG) assays are the most reliable in diagnosis and follow-up. Clin Chem 1990; 36: 234–9
   PubMed Web of Science ®Google Scholar
• Weintraub B D, Rosen SW. Ectopic production of isolated beta subunit of human chorionic gonadotropin. J Clin Invest 1973; 52: 3135–42
   PubMed Web of Science ®Google Scholar
• Rutanen E-M, Seppala M. The hCG-beta subunit radioimmunoassay in nontrophoblastic gynecological tumors. Cancer 1978; 41: 692–6
   PubMed Web of Science ®Google Scholar
• Oztuik M, Bellet D, Manil L, Hennen G, Frydman R, Wands J. Physiological studies of human chorionic gonadotropin (hCG), othCG and BhCG as measured by specific monoclonal immunoradiomelric assays. Endocrinol 1987; 120: 549–58
   PubMed Web of Science ®Google Scholar
• Papapetrou P D, Sakarelou N P, Braouzi H, Fessas PH. Ectopic production of human chorionic gonadotropin (hCG) by neoplasms: The value of measurement of immunoreac-tive hCG in the urine as a screening procedure. Cancer 1980; 45: 2583–92
   PubMed Web of Science ®Google Scholar
• Papapetrou P D, Nicopoulou SC. The origin of human chorionic gonadotropin β-subunit-core fragment excreted in the urine of patients wilh cancer. Acta Endocrinol 1986; 112: 415–22
   PubMedGoogle Scholar
• Birken S, Armstrong E G, Kolks M AG. Structure of the human chorionic gonadotropin B-subunit fragment from pregnancy urine. Endocrinol 1988; 123: 572–83
   PubMed Web of Science ®Google Scholar
• O'Connor J, Shlatterer J, Birken S, Krichevsky A, Armstrong E, McMahon D, Canfield R. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its B-subunit, and B core fragment in the urine: Application to malignancies. Cancer Res 1988; 48: 1361–6
   PubMed Web of Science ®Google Scholar
• Cole L A, Schwartz P E, Wang Y. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. I. Sensitivity and specificity, comparison wilh other markers. Gynecol Oncol 1988; 31: 82–90
   PubMed Web of Science ®Google Scholar
• Kardana A, Taylor M E, Soulhall P J, Boxer G M, Rowan A J, Bagshawe KD. Urinary gonadotroph– peptide - isolation and purification, and its immunohistological distribution in normal and neoplastic tissues. Br J Cancer 1988; 58: 281–6
   PubMed Web of Science ®Google Scholar
• Wang Y, Schwartz P E, Chambers J T, Cole LA. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. II. Initial serial studies. Gynecol Oncol 1988; 31: 91–100
   PubMed Web of Science ®Google Scholar
• Alfthan H, Haglund C, Roberts P, Stenman U-H. Elevation of free β-subunit serum levels in gastrointestinal inflammatory disease and pancreatic cancer. Fifth World Congress on Gestational Trophoblastic Diseases, London 1990; 3.-5.: 10, Abstract
   Google Scholar
• Lucky A W, Rich B H, Rosenfieid R L, Fang V S, Roche-Bender N. LH bioactivity increases more than immunore activity during puberty. J Pediatr 1980; 97: 205–13
   PubMed Web of Science ®Google Scholar
• Apler D, Cacciatore B, Alfthan H, Stenman U-H, Serum LH. concentrations increase 100-fold in females from 7 years of age to adulthood as measured by time-resolved immunofluorometric assay. J. Clin. Endocrinol. Metab. 1989; 68: 3–8
   PubMed Web of Science ®Google Scholar
• Dunkel L, Alfthan H, Stenman U-H, Tapanainen P, Perheen-Tupa J. Pulsatile secretion of LH and FSH in pubertal and early pubertal boys revealed by ultrasensitive time-resolved immunofluorometric assays. Pediatr Res 1990; 27: 215–9
   PubMed Web of Science ®Google Scholar
• Haavisto A-M, Dunkel L, Pettersson K, Huhtaniemi I. LH measurements by in vitro bioassay and a highly sensitive immunofluorometric asssay improve the distinction betweeen boys with constitutional delayed puberty and hy-pogonadotropic hypogonadism. Pediatr Res 1990; 27: 211–4
   PubMed Web of Science ®Google Scholar
• Pettersson K, Ding Y-Q, Huhtaniemi I. An immunologically anomalous LH variant in a healthy woman. Clin Chem, In press
   Google Scholar
• Celninker A C, Chen A B, Wen R M, Jr, Sherman BM. Variability in the quantitation of circulating growth hormone using commercial immunoassays. J Clin Endocrinol Metab 1989; 68: 469–76
   PubMed Web of Science ®Google Scholar
• Bonier U, Blind E, Vogel G, Hitzler W, Flentje D, Schmidt-Gayk H. Two-site immunochemoluminometric assay of intact human parathyrin in serum wilh use of a tracer peptide purified by reversed-phase high-performance liquid chromatography. Clin Chem 1989; 35: 215–22
   PubMed Web of Science ®Google Scholar
• While A H, Smilh M, Lloadley SH, Dobson S H, RatcUffe JG. Clinical evaluation of two-site immunoradiomelric assay for adrenocorticotropin in unextracled human plasma using monoclonal anybodies. Clin Endocrinol 1987; 26: 41–52
   PubMed Web of Science ®Google Scholar
• Zoubir F, Zeromski J, Sikora J, Szmeja J, Hedin A, Ham-Marstrom S. Tumor specificity of monoclonal antibodies to carcinoembryonic antigen. Immunohistochemical analysis. Tumour Biol 1990; 11: 5–19
   PubMedGoogle Scholar
• Nisselbaum J S, Smilh C A, Schwartz D, Schwartz MK. Comparison of Roche RIA, Roche EIA, Hybritech EIA, and Abbott EIA methods for measuring carcinoembryonic antigen. Clin Chem 1988; 34: 761–4
   PubMed Web of Science ®Google Scholar
• McKenzie I FC, Xing P-X. Mucins in breast cancer: recent immunological advances. Cancer Cells 1990; 2: 75–8
   PubMed Web of Science ®Google Scholar
• Gum J R, Byrd J C, Hicks J W, Toribara N W, Lamport D T, Kim YS. Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J Biol Chem 1989; 264: 6480–7
   PubMed Web of Science ®Google Scholar
• Gendler S, Taylor-Papadimilriou J, Duhig T, Rolhbard J, Burchell J. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem 1988; 26: 128820–3
   Google Scholar
• Girling A, Bankova J, Burchell J, Gendler S, Gillett C, Taylor PJ. A core protein epitope of the polymorphic epithelial mucin delected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer 1989; 43: 1072–6
   PubMed Web of Science ®Google Scholar
• Slamey T A, Yang N, Hay A R, McNeal J E, Freiha F S, Red-Wine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909–16
   PubMed Web of Science ®Google Scholar
• Stenman U-H, Leinonen J, Alfthan H, Alfthan O. A complex between prostate specicific antigen (PSA) and x-l -an-tichymotrypsin is ihe major form of PSA in serum of patients with prostatic cancer. Cancer Res 1991, in press
   Web of Science ®Google Scholar